Moulson Nathaniel, Petek Bradley J, Baggish Aaron L, Harmon Kimberly G, Kliethermes Stephanie A, Patel Manesh R, Churchill Timothy W, Drezner Jonathan A
Division of Cardiology and Sports Cardiology BC, University of British Columbia, Vancouver, BC V6T2B5, Canada.
Massachusetts General Hospital Division of Cardiology, Boston, MA 02114, USA.
J Cardiovasc Dev Dis. 2023 Feb 6;10(2):72. doi: 10.3390/jcdd10020072.
The Outcomes Registry for Cardiac Conditions in Athletes (ORCCA) study is a large-scale prospective investigation evaluating the cardiovascular effects and outcomes of SARS-CoV-2 infection on young competitive athletes. This review provides an overview of the key results from the ORCCA study. Results from the ORCCA study have provided important insights into the clinical impact of SARS-CoV-2 infection on the cardiovascular health of young competitive athletes and informed contemporary screening and return to sport practices. Key results include defining a low prevalence of both cardiac involvement and adverse cardiovascular outcomes after SARS-CoV-2 infection and evaluating the utility of a return-to-play cardiac evaluation. Future aims of the ORCCA study include the longer-term evaluation of cardiovascular outcomes among athletes post-SARS-CoV-2 infection and the transition to investigating outcomes in young athletes with potentially high-risk genetic or structural cardiac diagnoses.
运动员心脏疾病结局登记(ORCCA)研究是一项大规模前瞻性调查,旨在评估SARS-CoV-2感染对年轻竞技运动员的心血管影响和结局。本综述概述了ORCCA研究的主要结果。ORCCA研究的结果为SARS-CoV-2感染对年轻竞技运动员心血管健康的临床影响提供了重要见解,并为当代筛查和恢复运动实践提供了依据。主要结果包括确定SARS-CoV-2感染后心脏受累和不良心血管结局的低患病率,以及评估重返赛场心脏评估的效用。ORCCA研究的未来目标包括对SARS-CoV-2感染后运动员心血管结局的长期评估,以及转向调查具有潜在高风险遗传或结构性心脏诊断的年轻运动员的结局。